Patents by Inventor Bibi Shah Soltan Mirshahi

Bibi Shah Soltan Mirshahi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for in vitro assay of soluble fibrin by generating specific degradation products
    Patent number: 9081024
    Abstract: The invention concerns a method for assaying soluble fibrin in a sample, in which said sample is brought into the presence of a plasminogen activator with a high specificity for soluble fibrin (PA-Fb sp) and the soluble fibrin count in the sample is measured by measuring the difference between the count of fibrin degradation products obtained after degrading soluble fibrin with PA-Fb sp and the base count of fibrin degradation products determined before bringing the sample into the presence of PA-Fb sp.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: July 14, 2015
    Assignees: Societe Diagnostica-Stago, Assistance Publique-Hopitaux de Paris
    Inventors: Bibi Shah Soltan Mirshahi, Jeannette Soria
  • Method for in vitro assay of soluble fibrin by generating specific degradation products
    Patent number: 8883433
    Abstract: The invention concerns a method for assaying soluble fibrin in a sample, in which said sample is brought into the presence of a plasminogen activator with a high specificity for soluble fibrin (PA-Fb sp) and the soluble fibrin count in the sample is measured by measuring the difference between the count of fibrin degradation products obtained after degrading soluble fibrin with PA-Fb sp and the base count of fibrin degradation products determined before bringing the sample into the presence of PA-Fb sp.
    Type: Grant
    Filed: February 25, 2003
    Date of Patent: November 11, 2014
    Assignees: Societe Diagnostica-Stago, Assistance Publique-Hopitaux de Paris
    Inventors: Bibi Shah Soltan Mirshahi, Jeannette Soria
  • METHOD FOR IN VITRO ASSAY OF SOLUBLE FIBRIN BY GENERATING SPECIFIC DEGRADATION PRODUCTS
    Publication number: 20120070855
    Abstract: The invention concerns a method for assaying soluble fibrin in a sample, in which said sample is brought into the presence of a plasminogen activator with a high specificity for soluble fibrin (PA-Fb sp) and the soluble fibrin count in the sample is measured by measuring the difference between the count of fibrin degradation products obtained after degrading soluble fibrin with PA-Fb sp and the base count of fibrin degradation products determined before bringing the sample into the presence of PA-Fb sp.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 22, 2012
    Applicants: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, SOCIETE DIAGNOSTICA-STAGO
    Inventors: Bibi Shah Soltan Mirshahi, Jeannette Soria
  • Detection of venous thromboembolic diseases by measurement of D-dimers and soluble fibrin levels
    Patent number: 7968302
    Abstract: A method and a test for detecting coagulation activation, in particular when it is responsible for thromboembolic venous diseases; employs assaying D-dimers and assaying the soluble fibrin produced during a fibrinolysis process activated in a blood sample. The method of the invention pertains to comparing the level of D-dimers corresponding to degradation of soluble fibrin and the level of D-dimers of the sample with normal threshold values. The test of the invention may also be used to determine whether anti-coagulation is sufficient in a patient.
    Type: Grant
    Filed: May 3, 2007
    Date of Patent: June 28, 2011
    Assignees: Diagnostica Stago, Assistance Publique - Hopitaux de Paris
    Inventors: Bibi Shah Soltan Mirshahi, Jeannette Soria
  • DETECTION OF VENOUS THROMBOEMBOLIC DISEASES BY MEASUREMENT OF D-DIMERS AND SOLUBLE FIBRIN LEVELS
    Publication number: 20090305301
    Abstract: A method and a test for detecting coagulation activation, in particular when it is responsible for thromboembolic venous diseases; employs assaying D-dimers and assaying the soluble fibrin produced during a fibrinolysis process activated in a blood sample. The method of the invention pertains to comparing the level of D-dimers corresponding to degradation of soluble fibrin and the level of D-dimers of the sample with normal threshold values. The test of the invention may also be used to determine whether anti-coagulation is sufficient in a patient.
    Type: Application
    Filed: May 3, 2007
    Publication date: December 10, 2009
    Applicant: DIAGNOSTICA STAGO
    Inventors: Bibi Shah Soltan Mirshahi, Jeannette Soria
  • Method for in vitro assay of soluble fibrin by generating specific degradation products
    Publication number: 20030175839
    Abstract: The invention concerns a method for assaying soluble fibrin in a sample, in which said sample is brought into the presence of a plasminogen activator with a high specificity for soluble fibrin (PA-Fb sp) and the soluble fibrin count in the sample is measured by measuring the difference between the count of fibrin degradation products obtained after degrading soluble fibrin with PA-Fb sp and the base count of fibrin degradation products determined before bringing the sample into the presence of PA-Fb sp.
    Type: Application
    Filed: February 25, 2003
    Publication date: September 18, 2003
    Applicant: Societe Diagnostica-Stago
    Inventors: Bibi Shah Soltan Mirshahi, Jeannette Soria